Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active compa
| Image |  |
|---|---|
| Description | scientific article published on 29 December 2016 |
| Author/s |
author: Kim A. Papp Alexandra Boer Kimball Yaung-Kaung Shen Christopher Griffiths Andrew Blauvelt |
| Publication date | January 2, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |